These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24159708)

  • 1. [PMS and PMDD].
    Leminen H; Paavonen J
    Duodecim; 2013; 129(17):1756-63. PubMed ID: 24159708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
    Steiner M; Pearlstein T; Cohen LS; Endicott J; Kornstein SG; Roberts C; Roberts DL; Yonkers K
    J Womens Health (Larchmt); 2006; 15(1):57-69. PubMed ID: 16417420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The premenstrual syndrome].
    van der Leij F; Schultz WC; van de Wiel H; van Leeuwen JH
    Ned Tijdschr Geneeskd; 2010; 154():A1341. PubMed ID: 20719012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.
    Dunphy L; Boyle S; Wood F
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38160030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
    Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
    Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Premenstrual syndrome and premenstrual dysphoric disorder].
    Kovács Z; Hegyi G; Szőke H
    Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Brown J; O' Brien PM; Marjoribanks J; Wyatt K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
    Luisi AF; Pawasauskas JE
    Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
    Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
    Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.
    Frackiewicz EJ; Shiovitz TM
    J Am Pharm Assoc (Wash); 2001; 41(3):437-47. PubMed ID: 11372908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches].
    Lenzinger E; Diamant K; Vytiska-Binstorfer E; Kasper S
    Nervenarzt; 1997 Sep; 68(9):708-18. PubMed ID: 9411273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological aspects of premenstrual syndrome.
    Indusekhar R; Usman SB; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2007 Apr; 21(2):207-20. PubMed ID: 17175199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
    Steiner M
    J Psychiatry Neurosci; 2000 Nov; 25(5):459-68. PubMed ID: 11109297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices.
    Mitwally MF; Kahn LS; Halbreich U
    Expert Opin Pharmacother; 2002 Nov; 3(11):1577-90. PubMed ID: 12437492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual Dysphoric Disorder.
    Lanza di Scalea T; Pearlstein T
    Psychiatr Clin North Am; 2017 Jun; 40(2):201-216. PubMed ID: 28477648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premenstrual syndrome: A mini review.
    Ryu A; Kim TH
    Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.
    Inoue Y; Terao T; Iwata N; Okamoto K; Kojima H; Okamoto T; Yoshimura R; Nakamura J
    Psychopharmacology (Berl); 2007 Feb; 190(2):213-9. PubMed ID: 17072588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premenstrual dysphoric disorder. A guide for the treating clinician.
    Elliott H
    N C Med J; 2002; 63(2):72-5. PubMed ID: 12063908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.